Keloid imaging study with 68Ga-RGD PET-CT
Treatments studied
Part of Skin clinical trials.
This trial uses a special PET-CT scan to see if a tracer called 68Ga-RGD can help diagnose keloids. It may help doctors better understand and identify these scars.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a keloid diagnosed by a doctor.
- You must be able to give informed consent for the study.
- You cannot be pregnant.
- You cannot be a child (age 18 or older).
- You cannot have allergies to contrast dye used in scans.
- You cannot have claustrophobia (fear of enclosed spaces).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at using a specific PET/CT scan (a whole-body imaging test) to help evaluate cancer that is confirmed or suspected. If you are eligible, you may receive this scan soon after a recent FDG PET/CT to compare or improve how cancers are identified.
This early-phase study tests special PET/CT scans using a radioactive tracer to see cancer areas that have specific targets. It may help doctors better visualize tumors and plan next steps, using scans that you may already be familiar with (FDG) plus targeted tracers.
This trial studies how well a specific PET/CT scan using a radioactive tracer can detect or evaluate cancers. It may help doctors see where cancer is in the body more clearly.
This trial uses a special PET scan to see if a new imaging agent can find hard-to-treat pituitary tumors that have come back after surgery. It may help doctors decide the best way to manage these tumors.
This trial tests a new imaging method that uses a special dye to highlight a protein called Trop-2 found on some brain tumor cells. The goal is to see if this dye can help doctors see the tumor more clearly before surgery, which may improve surgical planning.
This trial tests a new imaging tracer called TATE-RGD to see if it can better spot certain tumors when used with a standard PET/CT scan. If you have cancer, you may be able to help by getting two scans a week apart.
Hear when a new Keloid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.